You are here

  • Home
  • Archive
  • Volume 82, Issue 8
  • Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al

Article info

Article menu
Download PDFPDF
Correspondence response
Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al

Authors

  • Martin Aringer Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Karen Costenbader Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Nicolai Leuchten Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Thomas Dörner Department of Medicine/Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Sindhu R Johnson Department of Medicine, Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto Scleroderma Research Program, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Martin Aringer, Internal Medicine III, TU Dresden, 01062 Dresden, Germany; martin.aringer{at}uniklinikum-dresden.de
View Full Text

Citation

Aringer M, Costenbader K, Leuchten N, et al
Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al
Annals of the Rheumatic Diseases 2023;82:e194.

Publication history

  • Received August 25, 2021
  • Accepted August 30, 2021
  • First published September 11, 2021.
Online issue publication 
July 13, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.